A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Miami, FL — U.S. Senator Marco Rubio (R-FL) sent a letter to Attorney General William Barr to follow up on inquiries made in regard to Federal Correctional Institute (FCI) Coleman, located in Sumter County, Florida.
“The delay in meaningfully responding to congressional oversight has eroded trust in the BOP, and has potentially endangered its staff, and the inmates in their care,” Rubio wrote. “FCI Coleman is BOP’s largest facility, with over 7,000 inmates and 1,300 staff. I request an update on the status of the prison task force and further request to expand my previous request to include FCI Coleman’s implementation and observance of the CDC’s COVID-19 guidance to correctional facilities.”
The full text of the letter is below.
Dear Attorney General Barr:
I write with dissatisfaction that the Department of Justice (DOJ) has not sufficiently responded to inquiries I have made in regard to Federal Correctional Institute (FCI) Coleman, located in Sumter County, Florida.
Nearly nine months ago, on December 9, 2019, I wrote to request that you conduct a review of all Bureau of Prisons (BOP) inmate and staff protocols, processes, reporting systems, and employee reviews after the Miami Herald published disturbing allegations of sexual abuse in the women’s camp at FCI Coleman. The Herald reported that more than a dozen female inmates alleged specific and detailed instances of sexual abuse at the hands of BOP employees, and were subjected to retaliatory punishment when they filed complaints. My office has not received a substantive response, or any indication that these abhorrent allegations were investigated.
On April 7, 2020, I followed up on this request, and urged you to investigate FCI Coleman as part of DOJ’s task force to address systemic misconduct by BOP personnel, which was announced in March 2020. Again, my office has not received a substantive response to this inquiry, and to date, the DOJ has not formed this task force or announced the facilities where oversight will be directed.
Separately, the COVID-19 pandemic has presented many challenges to detention practices in our federal prison system. BOP staff and the inmates in their care are at increased risk due to the congregate and enclosed environment where individuals live, eat, and work in group settings. Extra care must be taken to mitigate the spread of COVID-19 in federal prisons. To date, two FCI Coleman inmates have died from COVID-19, and there are 245 active cases among inmates and 96 active cases among staff.
Recognizing these challenges, in March BOP issued new policies that include reducing the federal inmate population, limiting inmate transfers between facilities, and quarantining new arrivals. However, my office continues to receive numerous complaints that FCI Coleman staff are not following the Centers for Disease Control’s (CDC’s) Guidance for Correctional and Detention Facilities, which – among other measures –recommends BOP officers and inmates wear masks when in close proximity with others. Most concerning, my office has been made aware that facility management may have ordered staff to return to work despite testing positive for COVID-19. I have already requested the BOP take immediate action to address this allegation, and I look forward to the outcome of its investigation.
The delay in meaningfully responding to congressional oversight has eroded trust in the BOP, and has potentially endangered its staff, and the inmates in their care. FCI Coleman is BOP’s largest facility, with over 7,000 inmates and 1,300 staff. I request an update on the status of the prison task force and further request to expand my previous request to include FCI Coleman’s implementation and observance of the CDC’s COVID-19 guidance to correctional facilities.
It is our shared goal that all BOP staff and individuals in their custody and care have a safe environment in which to work or serve their debt to society. My office stands ready to assist you in this endeavor.
Thank you for your attention to this matter.
Sincerely,